Article

#24: Visual Field Technology for Glaucoma Management

Assessment of the visual field was first established as a hallmark diagnostic tool to provide information about a patient’s visual function and quality of vision in the first half of the 20th century, but significant advances in technology have made visual field testing much more efficient and effective in the last 25 years.

Structure-function map developed with SPECTRALIS Glaucoma Module Premium Edition (not available for sale in all countries) and the Heidelberg Edge Perimeter (HEP).Assessment of the visual field was first established as a hallmark diagnostic tool to provide information about a patient’s visual function and quality of vision in the first half of the 20th century, but significant advances in technology have made visual field testing much more efficient and effective in the last 25 years.

Standard automated perimetry (SAP) became popularized in the late 1980s and early 1990s. White-on-white SAP is used to estimate threshold sensitivity measurements. SAP is currently considered to be most effective in patients with moderate-to-severe progressive glaucoma.

Since the introduction of SAP, a number of alternatives have been introduced that are primarily aimed at identifying patients with early glaucomatous damage and, consequently, fostering earlier treatment before the condition progresses. Many currently available machines use a combination of SAP with a newer technology. These newer alternatives include:

  • Short-wavelength automated perimetry (SWAP): Also known as blue-yellow perimetry, SWAP tests only a small fraction of the visual system by projecting a large Goldmann size V blue target on a bright yellow background.

  • Frequency-doubling technology (FDT) perimetry: FDT uses low-spatial-frequency sinusoidal grating undergoing rapid phase-reversal flicker that appears to have twice as many alternating light and dark bars than are actually present (hence the term “frequency doubling”). 

  • Flicker-defined form (FDF) perimetry: FDF uses a high-temporal-frequency stimulus that undergoes counterphase flicker, leading to a phantom contour illusion. Patients will typically perceive a gray patch or circle against the mean luminance background.

  • Visually evoked cortical potentials (VECP) and electroretinography: VECP involves cortical or retinal responses to a stimulus such as a flickering light or reversing patterns of light and dark squares. This multifocal technology can be useful in assessing retinal ganglion cell function.

The integration of the functional information provided by perimetry and the underlying structural information provided by diagnostic imaging methods such as optical coherence tomography is an area being explored to improve detection and management of glaucoma. Several studies suggest that combining structural and functional data from both testing modalities significantly enhances the clinical diagnosis and management of glaucoma. Furthermore, proper correlation of visual function to structural data points is critical for clinicians to make accurate use of this confirmatory data.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.